Use the RetaLABS reconstitution calculator for custom concentrations
Emerging incretin- and multi-agonist-based treatments: the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond
CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2
In patients treated with NAC, AST, ALT and ALP were significantly decreased after conditioning compared to their start values
This discovery established GHK-Cu as one of the first identified endogenous signaling molecules involved in age-related tissue decline
Become a Member to Receive Exclusive Content This website, my podcast, and my weekly email newsletter all focus on translating the science of longevity into something accessible, digestible, and actionable for everyone